EP3283650A4 - Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features - Google Patents

Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features Download PDF

Info

Publication number
EP3283650A4
EP3283650A4 EP16780662.9A EP16780662A EP3283650A4 EP 3283650 A4 EP3283650 A4 EP 3283650A4 EP 16780662 A EP16780662 A EP 16780662A EP 3283650 A4 EP3283650 A4 EP 3283650A4
Authority
EP
European Patent Office
Prior art keywords
microbiome
therapeutics
diagnostics
conditions associated
functional features
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP16780662.9A
Other languages
German (de)
French (fr)
Other versions
EP3283650A1 (en
Inventor
Zachary APTE
Daniel Almonacid
Jessica RICHMAN
Siavosh Rezvan BEHBAHANI
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Psomagen Inc
Original Assignee
uBiome Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by uBiome Inc filed Critical uBiome Inc
Publication of EP3283650A1 publication Critical patent/EP3283650A1/en
Publication of EP3283650A4 publication Critical patent/EP3283650A4/en
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
EP16780662.9A 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features Pending EP3283650A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562146818P 2015-04-13 2015-04-13
US201562147096P 2015-04-14 2015-04-14
US201562147334P 2015-04-14 2015-04-14
PCT/US2016/027349 WO2016168344A1 (en) 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diaganostics and therapeutics for conditions associated with functional features

Publications (2)

Publication Number Publication Date
EP3283650A1 EP3283650A1 (en) 2018-02-21
EP3283650A4 true EP3283650A4 (en) 2019-04-10

Family

ID=57126060

Family Applications (1)

Application Number Title Priority Date Filing Date
EP16780662.9A Pending EP3283650A4 (en) 2015-04-13 2016-04-13 Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features

Country Status (4)

Country Link
EP (1) EP3283650A4 (en)
CN (1) CN107849616B (en)
AU (2) AU2016250096A1 (en)
WO (1) WO2016168344A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3687375A4 (en) * 2016-11-21 2022-01-19 Psomagen, Inc. Method and system for characterizing a headache-related condition
WO2018112419A1 (en) * 2016-12-15 2018-06-21 uBiome, Inc. Method and system for characterizing diet-related conditions
EP3775257A4 (en) * 2016-12-15 2022-03-09 Psomagen, Inc. Method and system for characterizing allergy-related conditions associated with microorganisms
WO2018112459A1 (en) * 2016-12-16 2018-06-21 uBiome, Inc. Method and system for characterizing microorganism-related conditions
AU2019281024A1 (en) * 2018-06-07 2020-12-24 4D Pharma Plc Method for stratifying IBS patients
WO2020205542A1 (en) * 2019-03-29 2020-10-08 Psomagen, Inc. Microbiome byproducts and uses thereof
CN115691813A (en) * 2022-12-30 2023-02-03 神州医疗科技股份有限公司 Genetic gastric cancer assessment method and system based on genomics and microbiomics

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
US20140315929A1 (en) * 2011-04-28 2014-10-23 Sloan-Kettering Institute For Cancer Research Hsp90 combination therapy
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006097949A1 (en) * 2005-03-16 2006-09-21 Actial Farmacêutica, Lda. Mixture of at least 6 species of lactic acid bacteria and/or bifidobacteria in the manufacture of sourdough
JP2009514551A (en) * 2005-11-09 2009-04-09 プリメーラ バイオシステムズ インコーポレーティッド Multiple quantitative detection method for pathogens
WO2012050513A1 (en) * 2010-10-11 2012-04-19 Baeckhed Fredrik Method for identifying a risk of cardiovascular disease by analysing oral microbiota
US20140341853A1 (en) * 2013-05-14 2014-11-20 Vanna Hovanky Bacteria-Mediated Therapy for Cancer

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140315929A1 (en) * 2011-04-28 2014-10-23 Sloan-Kettering Institute For Cancer Research Hsp90 combination therapy
US20130121968A1 (en) * 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2015013214A2 (en) * 2013-07-21 2015-01-29 Whole Biome, Inc. Methods and systems for microbiome characterization, monitoring and treatment

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2016168344A1 *

Also Published As

Publication number Publication date
CN107849616B (en) 2022-03-29
AU2016250096A1 (en) 2017-11-09
WO2016168344A8 (en) 2018-07-26
EP3283650A1 (en) 2018-02-21
AU2022203347A1 (en) 2022-06-09
AU2016250096A8 (en) 2018-12-06
WO2016168344A1 (en) 2016-10-20
CN107849616A (en) 2018-03-27

Similar Documents

Publication Publication Date Title
EP3347495A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with gastrointestinal health
EP3209803A4 (en) Method and system for microbiome-derived diagnostics and therapeutics
EP3121613A4 (en) Degradation estimation method, degradation estimation system, and degradation estimation program
EP3283086A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features
GB2539260B (en) Control system, vehicle and method
EP3141073A4 (en) Methods, apparatus, and systems for determining communication priority
EP3347367A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for bacterial vaginosis
GB2539258B (en) Control system, vehicle and method
EP3346912A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with cerebro-craniofacial health
GB201510342D0 (en) Control system, vehicle and method
EP3283650A4 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
EP3199402A4 (en) Seat-back frame, method for preparing same, and seat-back for vehicle
GB2539253B (en) Control system, vehicle and method
EP3091786A4 (en) Apparatus, method and system for cell selection
GB201510271D0 (en) Control system, vehicle and method
EP3346910A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for eczema
GB2539270B (en) Control system, vehicle and method
EP3283084A4 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions
EP3283085A4 (en) Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features
EP3283649A4 (en) Method and system for microbiome-derived characterization, diagnostics, and therapeutics for cardiovascular disease conditions
EP3270096A4 (en) Measurement system, measurement method, and measurement program
EP3128385A4 (en) Risk evaluation system for process system, risk evaluation program, and risk evaluation method
EP3222769A4 (en) Control method and control system for wash aid, and wash aid
EP3111700A4 (en) System and method for ue-specific offloading
EP3270097A4 (en) Measurement system, measurement method, and measurement program

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20171020

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/569 20060101ALI20181025BHEP

Ipc: G16H 50/20 20180101ALI20181025BHEP

Ipc: G06F 19/18 20110101AFI20181025BHEP

Ipc: C12Q 1/68 20180101ALI20181025BHEP

Ipc: G01N 33/48 20060101ALI20181025BHEP

Ipc: G06F 19/24 20110101ALI20181025BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20190314

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20180101AFI20190311BHEP

Ipc: G16H 50/20 20180101ALI20190311BHEP

Ipc: G01N 33/569 20060101ALI20190311BHEP

Ipc: G01N 33/48 20060101ALI20190311BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20191015

19U Interruption of proceedings before grant

Effective date: 20191011

19W Proceedings resumed before grant after interruption of proceedings

Effective date: 20201201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

D18D Application deemed to be withdrawn (deleted)
RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: PSOMAGEN, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20231129